11th May


Veterinary Services Memorandum No. 800.213

The CVB recently updated VS Memorandum 800.213: Licensing Guidelines for Production Platform-Based, Non-Replicating, Nonviable Products. This Memo could impact licensing plans for products that are currently being manufactured under 9 CFR 107.1, and also addresses platform-based prescription products.

Share This :

No comments so far!

Leave a Comment

Your email address will not be published.